Evidence map›Paper›PMID 38245579›Full record

ArticleScientific reports2024

Inhibitory role of copper and silver nanocomposite on important bacterial and fungal pathogens in rice (Oryza sativa).

Arnab Roy Chowdhury, Rishikesh Kumar, Arabinda Mahanty, Koel Mukherjee, Sudhir Kumar, Kishor U Tribhuvan, Rishav Sheel, Srikanta Lenka, Binay K Singh, Chirantan Chattopadhyay and 3 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Arnab Roy ChowdhuryICAR-National Institute of Secondary Agriculture, Namkum, Ranchi, 834 010, Jharkhand, India.
Rishikesh KumarICAR-Indian Institute of Agricultural Biotechnology, GarhkhatangaRanchi, Jharkhand, 834 003, India.
Arabinda MahantyICAR-National Rice Research Institute, Cuttack, Odisha, 753006, India.
Koel MukherjeeBirla Institute of Technology, Mesra, Ranchi, Jharkhand, 835215, India.
Sudhir KumarICAR-Indian Institute of Agricultural Biotechnology, GarhkhatangaRanchi, Jharkhand, 834 003, India.
Kishor U TribhuvanICAR-Indian Institute of Agricultural Biotechnology, GarhkhatangaRanchi, Jharkhand, 834 003, India.
Rishav SheelICAR-Indian Institute of Agricultural Biotechnology, GarhkhatangaRanchi, Jharkhand, 834 003, India.
Srikanta LenkaICAR-National Rice Research Institute, Cuttack, Odisha, 753006, India.
Binay K SinghICAR-Indian Institute of Agricultural Biotechnology, GarhkhatangaRanchi, Jharkhand, 834 003, India.
Chirantan ChattopadhyayICAR-Indian Institute of Agricultural Biotechnology, GarhkhatangaRanchi, Jharkhand, 834 003, India.
T R SharmaICAR-Indian Institute of Agricultural Biotechnology, GarhkhatangaRanchi, Jharkhand, 834 003, India.
Vijai Pal BhadanaICAR-Indian Institute of Agricultural Biotechnology, GarhkhatangaRanchi, Jharkhand, 834 003, India.
Biplab SarkarICAR-Indian Institute of Agricultural Biotechnology, GarhkhatangaRanchi, Jharkhand, 834 003, India. biplab_puru@yahoo.co.in.
ICAR-Indian Institute of Agricultural Biotechnology · INBirla Institute of Technology, Mesra · INCentral Rice Research Institute · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rice (Oryza sativa) being among the most important food crops in the world is also susceptible to various bacterial and fungal diseases that are the major stumbling blocks in the way of increased production and productivity. The bacterial leaf blight caused by Xanthomonas oryzae pv. oryzae and the sheath blight disease caused by Rhizoctonia solani are among the most devastating diseases of the rice crop. In spite of the availability of array of chemical control, there are chances of development of resistance. Thus, there is a need for the nanotechnological intervention for management of disease in the form of copper and silver nano-composites. The copper (CuNPs) and silver nanoparticles (AgNPs) were synthesized using green route and characterized using different high throughput techniques, i.e., UV-Vis, FT-IR, DLS, XRD, FE-SEM, TEM. The particle size and zeta potential of synthesized CuNPs and AgNPs were found 273 nm and - 24.2 mV; 95.19 nm and - 25.5 mV respectively. The nanocomposite of CuNPs and AgNPs were prepared having particle size in the range of 375-306 nm with improved stability (zeta potential - 54.7 to - 39.4 mV). The copper and silver nanoparticle composites evaluated against Xanthomonas oryzae pv. oryzae and Rhizoctonia solani were found to have higher antibacterial (inhibition zone 13 mm) and antifungal activities (77%) compared to only the copper nanoparticle (8 mm; 62% respectively). Net house trials of nano-composite formulations against the bacterial blight of rice also corroborated the potential of nanocomposite formulation. In silico studies were carried out selecting two disease-causing proteins, peptide deformylase (Xanthomonas oryzae) and pectate lyase (Rhizoctonia solani) to perform the molecular docking. Interaction studies indicatedthat both of these proteins generated better complex with CuNPs than AgNPs. The study suggested that the copper and silver nano-composites could be used for developing formulations to control these devastating rice diseases.

Indexed as

Metal NanoparticlesOryzaRhizoctoniaXanthomonasCopperMolecular Docking SimulationPlant DiseasesSilverSpectroscopy, Fourier Transform InfraredCopperSilver

Identifiers

PMID38245579
PMCPMC10799878
OpenAlexW4391052494

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.